Inventor · disambiguated record
Aaron Nguyen
Also filed as: NGUYEN AARON · NGUYEN AARON N
10 granted patents·5 pending applications·12 citations·filing 2010–2022
84Inventor score
Top patents by PatentIndex Score
15 records- 0188US10328077B2Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomasCELGENE CORP·Filed 2017·Granted Jun 25, 2019·2 cites·17 claims
- 0285US10543213B2Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomasCELGENE QUANTICEL RES INC·Filed 2019·Granted Jan 28, 2020·1 cites·5 claims
- 0384US9125884B2Methods for treating cancers using oral formulations of cytidine analogsCELGENE CORP·Filed 2012·Granted Sep 8, 2015·3 cites·22 claims
- 0482US8841277B2Methods for treating non-small cell lung cancer using 5-azacytidineCELGENE CORP·Filed 2013·Granted Sep 23, 2014·5 cites·34 claims
- 0578US10849898B2Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomasCELGENE QUANTICEL RES INC·Filed 2019·Granted Dec 1, 2020·0 cites·14 claims
- 0675US10548896B2Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomasCELGENE QUANTICEL RES INC·Filed 2019·Granted Feb 4, 2020·0 cites·5 claims
- 0774US9693987B2Methods for treating cancers using oral formulations of cytidine analogsCELGENE CORP·Filed 2015·Granted Jul 4, 2017·1 cites·21 claims
- 0872US10960005B2Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomasCELGENE QUANTICEL RES INC·Filed 2020·Granted Mar 30, 2021·0 cites·12 claims
- 0966US9101579B2Inhibition of drug resistant cancer cellsCELGENE CORP·Filed 2013·Granted Aug 11, 2015·0 cites·6 claims
- 1057US2024417463A1Anti-cd47 antibodies and methods of use thereofADAGENE PTE LTD·Filed 2022·Application pending·0 cites
- 1153US2014357567A1Methods for treating cancers using oral formulations of cytidine analogsCELGENE CORP·Filed 2014·Application pending·0 cites
- 1252US2023242663A1Combination therapy comprising anti-cd137 antibodiesADAGENE PTE LTD·Filed 2021·Application pending·0 cites
- 1342US8492361B2Methods for treating non-small cell lung cancer using 5-azacytidineNGUYEN AARON N·Filed 2010·Granted Jul 23, 2013·0 cites·32 claims
- 1441US2015366936A1Inhibition of drug resistant cancer cellsCELGENE CORP·Filed 2015·Application pending·0 cites
- 1540US2015359810A1Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidineCELGENE CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron Nguyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →